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This integrative review aimed to identify and assess evidence available about the use of 
high-efficiency air filters, protective isolation and masks for infection prevention in patients 
submitted to hematopoietic stem cell transplantation during hospitalization. LILACS, 
PUBMED, CINAHL, EMBASE and the Cochrane Library were used to select the articles. Of the 
1023 identified publications, 15 were sampled. The use of HEPA filters is recommended for 
patients submitted to allogeneic transplantation during the neutropenia period. The level of 
evidence of protective isolation is weak (VI) and the studies evaluated did not recommend 
its use. No studies with strong evidence (I and II) were evaluated that justify the use 
of masks, while Centers for Disease Control and Prevention recommendations should be 
followed regarding the use of special respirators by immunocompromised patients. The 
evidenced data can support decision making with a view to nursing care.
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Medidas utilizadas na prevenção de infecções em transplante de 
células-tronco hematopoéticas: evidências para a prática
Esta revisão integrativa teve como objetivo identificar e avaliar as evidências disponíveis 
em relação ao uso de filtros de ar de alta eficiência, isolamento protetor e máscaras 
para a prevenção de infecção em pacientes submetidos ao transplante de células-tronco 
hematopoéticas, durante a internação. Para a seleção dos artigos foram utilizadas as 
bases de dados LILACS, PubMed, CINAHL, EMBASE e a Biblioteca Cochrane. Das 1023 
publicações identificadas, 15 foram incluídas na amostra. O uso dos filtros HEPA é 
recomendado para pacientes submetidos ao transplante alogênico, durante o período 
de neutropenia. O nível das evidências do isolamento protetor é fraco (VI) e os estudos 
avaliados não recomendam o seu uso. Não foram avaliados estudos com evidências 
fortes (I e II) que justifiquem o uso de máscaras, sendo indicado que sejam seguidas 
as recomendações dos Centers for Disease Control and Prevention quanto ao uso de 
respiradores especiais pelos pacientes imunocomprometidos. Os dados evidenciados 
podem auxiliar na tomada de decisão para a assistência de enfermagem.
Descritores: Transplante de Células-Tronco Hematopoéticas; Transplante de Medula 
Óssea; Infecção; Filtração do Ar; Isolamento de Pacientes; Máscaras.
Medidas utilizadas en la prevención de infecciones en trasplante de 
células tronco hematopoyéticas: evidencias para la práctica
Esta revisión integradora tuvo como objetivo identificar y evaluar las evidencias 
disponibles en relación al uso de filtros de aire de alta eficiencia, aislamiento protector y 
máscaras en la prevención de infección en pacientes sometidos al trasplante de células 
tronco hematopoyéticas durante la internación. Para la selección de los artículos fueron 
utilizadas las bases de datos LILACS, PUBMED, CINAHL, EMBASE y la Biblioteca Cochrane. 
De las 1023 publicaciones identificadas, 15 fueron incluidas en la muestra. El uso de los 
filtros HEPA es recomendado para pacientes sometidos al trasplante alogénico durante 
el período de neutropenia. El nivel de las evidencias del aislamiento protector es débil 
(VI) y los estudios evaluados no recomiendan su uso. No fueron evaluados estudios con 
evidencias fuertes (I y II) que justifiquen el uso de máscaras, siendo indicado que deben 
ser seguidas las recomendaciones de los Centers for Disease Control and Prevention en lo 
que se refiere al uso de respiradores especiales por los pacientes inmunocomprometidos. 
Los datos evidenciados pueden auxiliar en la toma de decisiones para la asistencia de 
enfermería.
Descriptores: Trasplante de Células Madre Hematopoyéticas; Trasplante de Médula Ósea; 
Infección; Filtración del Aire; Aislamiento de Pacientes; Máscaras.
Introduction
Today, hematopoietic stem-cell transplantation 
(HSCT) represents a treatment alternative for different 
types of illnesses(1), including malign and non-malign 
blood diseases, immunodeficiencies, innate metabolic 
errors and solid tumors(2). It is considered a risk 
procedure, due to possible complications, particularly 
possible adverse and transfusion reactions when the 
hematopoietic stem cells (HSC) are infused(3), liver, 
hemorrhage, kidney, lung, neurological, heart, infectious 
and gastrointestinal complications.
The occurrence of infections is mainly related to the 
immunosuppression the conditioning regimen causes 
and constitutes an important cause of morbidity and 
mortality in these patients(2). Any category of causal 
agent can cause infections in any transplantation type 
or phase.
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One of the most concerning phases is the 
neutropenia that precedes the CTH graft, during which 
infection prevention measures are fundamental for 
successful treatment.
While some of these measures are based on 
scientific knowledge and follow Centers for Disease 
Control and Prevention (CDC) guidelines, others are 
based on experiences and personal opinions and have 
been a source of disagreement. Also, despite the 
existence of CDC guidelines on prevention measures, 
some are used with little consensus, particularly the use 
of high efficiency particulate air filters (HEPA), masks 
and protective isolation.
The function of HEPA filters is to prevent fungal 
infections, which is one of the items in the protective 
environment the CDC recommend for patients submitted 
to allogeneic HSCT(4-5). Although indicated for allogeneic 
HSCT, it is also used in autologous HSCT. On the opposite, 
due to their high cost and difficult maintenance, some 
centers have abolished their use, even for allogeneic 
HSCT.
Regarding protective isolation, this concept was 
introduced for the first time in 1970 and meant patients’ 
confinement to a private room and use of sterilized 
gowns, masks and gloves for care delivery(6); since 
that time, great variations have been observed in the 
component items of this isolation.
As experience showed that protective isolation did 
not fulfill its proposed goals, as a majority of infections 
came from endogenous flora, the CDC extinguished the 
recommendation for its use in 1983(7). Nevertheless, 
many centers continued using it, which aroused countless 
inquiries on the efficacy of this measure.
The use of masks for infection transmission 
prevention is another controversial point that has been 
used empirically in many situations.
In view of these divergences, the need was 
verified to survey information with a view to guiding 
professionals on the use of these measures. Nurses 
play a fundamental role in this context, as they are 
part of care delivery to patients and their relatives in all 
transplantation phases(1).
In view of the above, Evidence Based Practice 
(EBP) was selected as the theoretical framework. In this 
problem-solving approach, research results are used 
for decision making in practice. It is developed through 
the production of literature review methods that permit 
seeking, assessing and summarizing available evidence 
on the research theme(8). Thus, an integrative literature 
review was developed, which does not only present 
the current state of science, but also contributes to the 
development of theories and is applicable in practice(9).
This study aimed to identify and assess available 
evidence in literature on the use of HEPA filters, 
protective isolation and masks by patients, health 
professionals and/or visitors for infection prevention in 
patients submitted to HSCT during hospitalization.
Methods
An integrative is considered the systematic analysis 
and synthesis of research on a target theme. Its scope 
can be broad or restricted and the analysis type is 
descriptive. The method aims to reduce uncertainties 
on performed practices and to facilitate the decision 
process on actions and interventions that can result in 
more effective and cost-efficient health care(10).
To elaborate this review, six phases were performed: 
identification of the theme or question of the integrative 
review, sampling or literature search, study ranking, 
study assessment, result interpretation and presentation 
of the integrative review(9,11-13).
The guiding question was elaborated based on the 
PICO strategy, which stands for patient, intervention, 
comparison and outcomes. This current proposal 
helps to elaborate the clinical question and identify 
the descriptors that will be used to locate the studies, 
so as to maximize the recovery of evidence from the 
databases and focus on the research scope(14).
Thus, to construct the guiding question, P were the 
patients submitted to HSCT, I the use of HEPA filters, 
protective isolation and/or masks, C the comparison of 
these interventions with other possible interventions or 
not, and O the occurrence of infection. The question was 
formulated as: What evidence is available on the use of 
HEPA filters, protective isolation and masks for infection 
prevention in patients submitted to HSCT?
To select the articles, LILACS, CINAHL, MEDLINE, 
EMBASE and the Cochrane Library were consulted, 
using different search strategies with controlled and 
uncontrolled descriptors. Controlled descriptors are 
terms from a structured and organized vocabulary, 
that is, a topical descriptor used to index papers in the 
databases(15), while non-controlled means that the term 
is not part of the “topical descriptor” and represents the 
textual words and their synonyms identified based on 
the reading of primary texts. The following controlled 
descriptors were selected: bone marrow transplantation, 
hematopoietic stem-cell transplantation, infection, 
infection control, patient isolation, respiratory protection 
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devices, masks, air, filtration and air filtration: non 
controlled descriptors were: protective isolation, HEPA 
filters, laminar air flow, surgical mask and N95 mask.
The inclusion criteria were as follows: papers 
discussing care related to protective isolation, use of 
HEPA filters and/or masks for infection prevention in 
patients submitted to HSCT during hospitalization; 
published in journals; in English, Spanish or Portuguese; 
in the last 20 years. The exclusion criteria were: studies 
that included different populations of neutropenic 
patients in which results are presented in a generalized 
way; and publications that do not fit into the evidence 
level classification used(16).
This classification covers seven evidence levels, 
with level I: evidence coming from systematic reviews or 
meta-analyses of relevant randomized controlled clinical 
trials (RCCT) or of clinical guidelines based on systematic 
reviews of RCCT; level II: evidence deriving from at 
least one well-designed RCCT; level III: evidence from 
well designed clinical essays without randomization; 
level IV: evidence from well designed case-control or 
cohort studies; level V: evidence from systematic review 
of qualitative and descriptive studies; level VI: evidence 
from one single descriptive or qualitative study; level 
VII: evidence from expert opinions and/or expert 
committee reports. As this classification is based on the 
study design and its ability to affirm cause and effect, 
levels I and II are considered strong evidence, III and IV 
moderate and V to VII weak(16).
The titles and abstracts of 1023 identified studies 
were read, resulting in the pre-selection of 49. After 
reading the full papers, 34 were excluded for the 
following reasons: publications in German and Japanese 
(n = 2), results presented without distinction between 
HSCT patients and those submitted to other types of 
chemotherapy (n = 3), studies related to air, environment 
and/or ventilation system control and surveillance (n = 
6), research focus on other interventions or results (n = 
9), publications that did not fit into the adopted evidence 
level ranking (narrative literature review, abstract, letter 
to the editor and guideline, n = 13), and impossibility to 
get access to the full version of the article (n = 1).
Thus, 15 studies were selected, seven of which 
located in PUBMED, two in EMBASE, five in both PUBMED 
and EMBASE, and one in these two databases and the 
Cochrane Library. To extract the data from the papers, 
an instrument was used which nurses have previously 
employed(17). The selected publications were classified 
according to the methodological design and evidence 
level(12) and data synthesis was presented descriptively 
according to the following theme categories: use of HEPA 
filter, use of protection isolation and use of masks.
Results
The publications were included in the theme 
categories, use of HEPA filter (n = 10), use of protective 
isolation (n = 9) and use of masks (n = 2). The same 
study may have been included in more than one 
category.
As for the research institution, twelve (80%) were 
conducted in hospitals, while the remainder (20%) was 
not linked with any institution, with one meta-analysis, 
one survey and one expert opinion. Four studies (26.6%) 
were published in Bone Marrow Transplantation, five 
(33.3%) in journals related to HSCT, hematology and/
or oncology: and three (20%) papers were published in 
journals on infection; most papers came from England 
(46.6%) and the United States of America (40%).
As for the research design and evidence level(16), 
one study was classified as evidence level I (systematic 
review and meta-analysis), one as level IV (cohort 
study), one level V (systematic review of descriptive 
studies), eleven level VI (descriptive studies), and one 
level VII (expert opinion).
Figure 1 displays the synthesis of papers included 
in this integrative review(18-32). Five studies were 
included which involved different neutropenic patient 
populations(19-21,24,26), as results on HSCT receptors were 
presented independently.
Study Category Design/Sample
Aim/
Intervention Main results
Conclusion/
Recommendation
Barnes, 
Rogers(18)
HEPA filter Descriptive Check the incidence of invasive 
pulmonary aspergillosis before 
and after the installation of 
the HEPA filter at an HSCT 
unit. Buildings were being 
constructed nearby during 
the study period. Half of the 
children transplanted before 
and half after the opening of the 
filter unit.
32% of children transplanted 
before the opening of the 
unit equipped with a filter 
died of invasive pulmonary 
aspergillosis. After the new 
unit opened, no further 
cases of aspergillosis were 
identified. 
The HEPA filter can 
offer protection against 
airborne fungal infections.38 children 
submitted to 
allogeneic HSCT.
(Figure 1 continue in the next page...)
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(continuation)
Study Category Design/Sample
Aim/
Intervention Main results
Conclusion/
Recommendation
Johnson et 
al.(19)
HEPA filter Expert opinion To present European 
professionals’ 
recommendations on fungal 
infection prevention in 
immunocompromised patients.
A general recommendation 
is the HEPA filter in 
allogeneic HSCT, although 
environmental and/or patient 
surveillance is needed even 
in rooms with a HEPA filter. 
The HEPA filter is 
recommended in 
allogeneic HSCT. In 
autologous HSCT, the risk 
of infection needs to be 
verified before indicating 
its use.
Oren et al.(20) HEPA filter Descriptive Check the incidence of invasive 
pulmonary aspergillosis. The 
study was developed in three 
phases. In the first, patients 
did not receive antifungal 
prophylaxis; in the second, 
prophylaxis was started with 
amphotericin B and, in the 
third, besides amphotericin B, 
the HEPA filter was installed 
at the unit. During the study, 
constructions and reforms 
happened at the hospital.
In the first and second 
phases, aspergillosis 
incidence levels were 50% 
and 43%, respectively. This 
infection was not diagnosed 
in the third phase at the 
new unit. However, 29% of 
leukemia patients treated 
at conventional units in the 
same period developed 
aspergillosis. Spore counts 
in room air were significantly 
higher in the first and second 
phases.
The non occurrence of 
fungal infections can be 
attributed to the use of 
filters and is not related 
with amphotericin B 
prophylaxis.
1st phase: 12 
patients with 
acute leukemia
2nd phase: 28 
patients with 
acute leukemia
3rd phase: 26 
patients with 
acute leukemia, 
168 submitted to 
autologous and 
26 to allogeneic 
HSCT.
Hahn et 
al.(21)
HEPA filter Cohort study To investigate the cause of an 
A. flavus infection episode at a 
unit divided in hematology and 
HSCT wards. The HSCT wards 
were equipped with a HEPA 
filter, but the nursing station 
was shared by both units and 
did not have a filter.
In the first semester of the 
study year, no cases of 
aspergillosis were identified. 
In the second semester, 
10 patients (18%) were 
diagnosed with infection 
(one submitted to HSCT). 
Conidiospore counts in 
the air were higher at the 
hematology unit, with a 
mildewed wall close to 
the nursing station as the 
apparent source. 
According to the authors, 
the HEPA filter prevented 
cases of aspergillosis. 
Its use is recommended 
for patients with malign 
hematological diseases.
91 adult patients 
submitted 
to HSCT or 
treatment 
for onco-
hematological 
diseases.
Krüger et 
al.(22)
HEPA filter Descriptive
232 patients 
submitted to 
autologous and 
448 to allogeneic 
HSCT.
Check the incidence of 
aspergillosis and monitor the air 
at an HSCT unit. A construction 
area was present near the 
unit. The wards possessed a 
HEPA filter, an anteroom with 
double doors and positive 
pressure. The unit door close 
to the construction area was 
sealed with adhesive tape, and 
the entry changed to another 
location.
During the entire study, air 
contamination was greater in 
corridors and the construction 
area than in the wards. 
During the construction, 
the spore load in the air 
was higher in the corridor 
than in the wards. After the 
construction, the external 
area became part of the 
ward corridor, without any 
difference in spore counts 
inside the rooms. Incidence 
levels of aspergillosis were 
similar to other periods 
(3.6%).
Fungal spore counts 
in rooms with a HEPA 
filter, double doors and 
positive pressure were 
lower in comparison with 
environments without a 
filter. 
Nihtinen et 
al.(23)
HEPA filter Descriptive Check the incidence of 
aspergillosis at an HSCT 
ward equipped with a HEPA 
filter, sealed windows and 
double doors during a nearby 
construction. A barrier was 
constructed around the 
construction area and a 
surveillance scheme was 
proposed.
Particle and spore counts 
in the air were significantly 
higher in the external area 
than inside rooms. The 
samples of nasal cavity 
material were negative. 31% 
of oral cavity samples tested 
positively for C. albicans. No 
cases of aspergillosis were 
diagnosed.
The use of a HEPA filter 
can reduce the incidence 
of aspergillosis and 
contamination originating 
in construction dust.
07 patients 
submitted to 
autologous, 15 
to allogeneic 
HSCT and 33 
rehospitalizations 
of previously 
transplanted 
patients.
(Figure 1 continue in the next page...)
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Study Category Design/Sample
Aim/
Intervention Main results
Conclusion/
Recommendation
Passweg et 
al.(24)
HEPA filter Descriptive Check whether the use of 
the HEPA filter influences 
transplantation results. IBMTR 
data were used and patients 
were included in the groups that 
used a HEPA filter (n = 4238) or 
conventional protective isolation 
(individual rooms with any 
combination of measures like 
hand washing, gloves, masks 
and gowns, n = 827).
HSCT with HLA identical 
donors: no difference in 
fungal pneumonia cases 
occurred between both 
groups. HSCT with alternative 
donors: greater probability 
of fungal pneumonia among 
transplanted patients < 
25 years in conventional 
isolation. This difference was 
not significant in the group > 
25 years.
The use of a HEPA filter 
seemed to decrease 
transplantation-related 
mortality and increase 
survival after allogeneic 
transplantation. This 
benefit was more 
evident among patients 
with donors with HLA 
disparities.
Protective 
isolation
5065 patients 
submitted to 
allogeneic HSCT 
for leukemia.
The probability of survival 
was greater in groups treated 
in rooms with a HEPA filter 
than in conventional isolation.
Krüger et 
al.(25)
HEPA filter Descriptive Assess the situation 
of strategies against 
infection used in European 
transplantation centers through 
a survey.
Autologous HSCT: HEPA filter 
used in 47.2% and reverse 
isolation in 63.6% of centers. 
Facial masks were used by 
65.1% of professionals and 
60.8% of visitors. Allogeneic 
HSCT: 60.6% of centers 
used a HEPA filter and 78% 
reverse isolation. 74.2% of 
professionals and 63.6% of 
visitors used facial masks.
The strategies used 
in allogeneic HSCT 
are explained by high 
morbidity and mortality 
related to infection; 
strategies used in 
autologous HSCT do 
not reflect treatment 
development and differ 
from current guidelines.
Protective 
isolation
180 HSCT 
centers registered 
in the European 
BMT Group.
Masks
Schlesinger 
et al.(26)
HEPA filter Systematic review 
and meta-analysis
Perform a systematic review 
and meta-analysis of studies 
that assessed infection control 
measures for cancer patients 
submitted to chemotherapy. 
The two main interventions 
analyzed were protective 
isolation (including air filter use 
combined with endogenous 
flora barrier or suppression 
measures in this case) and 
outpatient care.
In the allogeneic HSCT 
group (n = 5931) and in the 
autologous HSCT or acute 
leukemia group (n = 916), 
a significant decrease in 
mortality and infections was 
verified.
The HEPA filter should 
be reserved for high-risk 
patients and for places 
where episodes occurred. 
Antibiotics mediated 
the beneficial effects of 
protective isolation. The 
use of barrier measures 
can reduce the incidence 
of cross-infection.
Protective 
isolation
40 prospective 
studies that 
addressed 
care delivery to 
autologous or 
allogeneic HSCT 
patients, or to 
chemotherapy 
patients due to 
hematological 
diseases or solid 
tumors.
Barrier isolation significantly 
contributed to reduce 
candidiasis and gram-positive 
infections. The use of isolated 
antibiotics showed to reduce 
all mortality causes.
Kumar et 
al.(27)
HEPA filter Descriptive Present the experience of 
allogeneic HSCT patients in 
individual rooms without a 
HEPA filter. Patients received 
antimicrobial prophylaxis, 
people who entered the room 
were advised to change shoes, 
put on mask and cap and 
wash hands. A diet with a low 
microbial load was permitted. 
95% of patients presented 
fever and, in 50%, no 
infection was diagnosed. 
In most positive blood 
cultures, pathogens from 
endogenous flora were found. 
One patient (2.5%) with 
probable pre-transplantation 
fungal pneumonia died on 
D+66. After D+100, eight 
deaths occurred and, in 
one case, aspergillosis and 
disseminated tuberculosis 
were the probable cause of 
death.
Low initial mortality 
and absence of severe 
infections suggest that 
allogeneic HSCT can 
be performed in rooms 
without a HEPA filter. 
Antimicrobials would be 
used more selectively if 
the filter were present.
Protective 
isolation
40 patients 
submitted to 
allogeneic HSCT
(Figure 1 continue in the next page...)
(continuation)
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Study Category Design/Sample
Aim/
Intervention Main results
Conclusion/
Recommendation
Tejada et 
al.(28)
Protective 
isolation
Descriptive Assess the incidence of 
infection. Individual rooms, 
reverse isolation, barrier 
measures, air filters (for 
gross particles), sterile 
diet, decontamination of 
gastrointestinal tract and 
degerming solution for bathing 
were used.
73% of patients were used. 
Five displayed inflammatory 
signs related to the central 
catheter. Microorganisms 
were isolated in 12 allogeneic 
receptors, 07 of which were 
bacteremia caused by S. 
epidermidis. 
Reverse isolation with 
a simple barrier permits 
transplantation in safe 
conditions, without 
the need for more 
sophisticated equipment.
09 children 
submitted to 
autologous and 
22 to allogeneic 
transplantation.
Russell et 
al.(29)
Protective 
isolation
Descriptive Check the benefits of protective 
isolation to prevent infections 
in HSCT. Individual rooms were 
used and isolation measures 
were abolished. Patients could 
leave the hospital, a diet with a 
low microbial load was offered, 
antimicrobial prophylaxis, 
without any orientation as 
to changes in the home 
environment. 
No cases of bacteremia by 
gram-negative or fungal 
infections occurred, 82% of 
patients presented fever, and 
pneumonia was diagnosed in 
three cases. In 22% of blood 
cultures, S. epidermidis grew. 
The 20 patients who lived 
in the city where the HSCT 
center was located could 
go home, generally at night, 
on average for eight days, 
and three spend 90% of 
the time outside the unit. Of 
the 20 patients, seven were 
discharged before the graft.
HSCT can be performed 
safely without the use 
of protective isolation or 
patients’ confinement 
inside the hospital.
50 adult patients 
submitted to 
allogeneic HSCT.
Dekker et 
al.(30)
Protective 
isolation
Descriptive Assess results of antimicrobial 
prophylaxis in patient groups 
with or without protective 
isolation. This involved 
individual rooms, use of 
mask, cap, gown, gloves and 
foot protectors, diet with low 
microbial load and sterilized 
objects. 
Patients older 
than 16 years 
submitted to 
autologous HSCT, 
59 with and 54 
without protective 
isolation.
HSCT with isolation: 25 
infections were diagnosed, 
two patients died of 
aspergillosis and candidiasis.
Isolation is not 
recommended as no 
benefits were found 
related to its use.
HSCT without isolation: 19 
infections were diagnosed, 
two died of infection 
(Acinetobacter isolate in one 
case and pneumonia in the 
other, without identifying the 
causal agent).
Russel et 
al.(31)
Protective 
isolation
Descriptive Assess infection and mortality 
patterns related to HSCT 
during the first 100 days post-
transplantation. HSCT were 
performed in individual rooms, 
patients could freely leave the 
room and the hospital, received 
antimicrobial prophylaxis, diet 
with low antimicrobial load, and 
no orientations on changes at 
home.
During the first 28 days, 
57% of patients had a fever, 
30presented clinical or 
radiological foci, besides 
positive cultures. In 25% of 
collected urine cultures, S. 
epidermidis was found and, 
in 25%, C. albicans. Four out 
of 38 deaths during the first 
100 days were caused by 
Aspergillus species. 25% of 
hospitalization days occurred 
outside the unit.
Protective isolation is 
not recommended and 
a HEPA filter should be 
used in case of airborne 
infections at the HSCT 
unit.
288 patients 
submitted to 
allogeneic HSCT.
Mank, 
Lelie(32)
Protective 
isolation
Systematic review This study was a systematic 
literature review on the use of 
protective isolation, a survey on 
infection prevention practices, 
assessment of potential 
infection sources at an HSCT 
unit, and a monitoring study on 
infection incidence before and 
after protective isolation had 
been banished.
In the review, no difference 
in infection incidence 
levels was found between 
patients in isolation or not. 
In the survey, differences 
were observed among the 
centers regarding the use of 
masks, gloves, gowns and 
alcohol for hand cleaning. 
Professionals’ hands 
represented an important 
source of microorganisms. 
The monitoring study showed 
similar infection rates in both 
groups. 
The use of protective 
isolation can be 
interrupted and adequate 
hand hygiene is needed.Masks Survey: 101 European 
hospitals
Monitoring: 81 
acute leukemia 
and 97 HSCT 
patients.
Figure 1 – Synthesis of studies included in the integrative review, Ribeirão Preto, Brazil, 2010
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Analysis of data extracted from the papers
HEPA filters can remove up to 99.97% of suspended 
particles with a maximum diameter of 0.3 µm. Its 
main function is to prevent airborne fungal infections, 
especially those caused by Aspergillus species, with 
mortality rates amounting to 95%. In guidelines 
published on opportunistic infection prevention among 
HSCT receivers(4-5,33), the use of a protective environment 
is recommended, aimed at minimizing fungal spore 
counts in the air and to reduce the risk of environment-
related invasive fungal infection among allogeneic HSCT 
receivers, with HEPA filters as one item in the protective 
environment.
As evidenced in the analyzed studies(18,20,22-23), filters 
are particularly important in sites nearby constructions, 
as these are an important risk factor for airborne fungal 
infections. Thus, despite weak evidence levels, the results 
of the analyzed studies support CDC recommendations 
for filter use in allogeneic transplantations, especially in 
case of fungal infection episodes and during constructions 
or activities that produce dust at the transplantation 
unit or nearby(4-5). Data presented in an evidence level 
I study also support recommendations regarding filter 
use(26). Only one study(27), also descriptive, reported 
that filters would not be needed, although the authors 
remained cautious, as the sample was limited and other 
measures, such as antifungal agents, were used against 
the possibility of this infection type.
Regarding autologous transplantations, although 
some studies report that using filters would be prudent in 
this population(20-21,23,25), further research is needed The 
evidence level I study included in the sample rejected 
this indication(26).
According to CDC guidelines(4), although the need 
to use HEPA filters for autologous transplantation 
receivers had not been established yet at the time the 
guideline was published, it was already reported that 
its use should be assessed for these patients in case 
of prolonged neutropenia. As recommendations refer to 
allogeneic HSCT, each unit’s conditions, characteristics 
and reality need to be assessed for decision making on 
filter use for autologous receivers.
Positive results on the use of HEPA filters are also 
evidenced in studies that, after the start of transplantations 
at a unit with a HEPA filter, observed a reduction in the 
incidence of aspergillosis(34). Some researchers, however, 
are cautious to affirm the utility of this equipment as, 
despite the decrease in fungal infection rates, no reduction 
in mortality rates was observed(35).
It was observed in the studies that other protective 
environment measures(5,33) were also used, including 
positive air pressure between the entry hall and rooms, 
directed air flow, automatic closing doors, room sealing 
to prevent air from entering, gasket of ventilation pipes 
and construction of rigid barriers to impede the entry of 
dust and Aspergillus spores at the HSCT units.
Regarding protective isolation, the CDC abolished 
the recommendation for its use in the 1980’s . Until 
today, however, it has been used and can include 
different combinations of measures, as evidenced in the 
analyzed studies.
Although researchers report that protective isolation 
can be used safely to perform transplantations(27-28), it 
should be highlighted that this consideration refers to 
situations in which the HEPA filter is not available and 
that this recommendation was based on research data 
with weak evidence levels. Although the results of an 
evidence level I study indicated that protective isolation 
was effective(26), it should be taken into account that, in 
this case, the HEPA filter was considered a protective 
isolation item.
About protective isolation measures, in one study(26), 
it is highlighted that the use of barrier measures is very 
important nowadays due to high resistant pathogen 
rates inside hospitals. This recommendation, however, is 
considered in disagreement with CDC recommendations. 
Hand washing, use of standard precautions and 
transmission-based precautions, when necessary, are 
sufficient to prevent cross infections when adequately 
used(4).
The results of most analyzed studies are in line with 
CDC indications. The main reason to abolish the use of 
this measure is based on the fact that causal agents 
of infections affecting these patients in the neutropenia 
phase are mostly microorganisms from endogenous 
flora, which affect the bloodstream or deep organs due 
to the rupture of the cutaneous and mucous barriers. 
In these cases, the use of diets with low antimicrobial 
loads is suggested, as well as decontamination of the 
gastrointestinal tract with non-absorbable oral antibiotics 
and use of antimicrobial prophylaxis.
Furthermore, as highlighted in two descriptive 
studies(29,31), the possibility of outpatient HSCT needs 
to be taken into account. In studies that assessed the 
effects and results of this transplantation mode, it was 
verified that graft time, fever, days using antibiotics, 
percentage of positive blood cultures and infections types 
were similar between groups treated at the hospital or 
in an outpatient scheme. These data indicate that this 
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type of program is safe, increases patients and families’ 
quality of life and maximizes the use of hospital beds 
and resources(36).
Other researchers did not manage to identify 
significant differences in infection or mortality rates 
either, between patients kept in protective isolation 
and patients who were not isolated(37). Hence, it is 
recommended that, when possible, HSCT receivers 
be placed in individual rooms(33), without the need for 
barrier measures.
Regarding patients, professionals or visitors’ use of 
masks, only two surveys were identified in which the use of 
this equipment at the transplantation units was reported 
on as a measure to prevent airborne infections(25,32). 
These results cannot sustain recommendations for their 
use.
According to current guidelines(5), professionals 
should use surgical masks as individual protection 
equipment. Their use is not indicated as an infection 
transmission prevention measure. To reduce the 
transmission of airborne pathogens, people with upper 
airway infection symptoms need to be screened in 
order to avoid contact with HSCT receivers, and need 
to be dismissed from care delivery to patients. Also, 
professionals need to be vaccinated(4).
Although masks are used as part of infection control 
programs caused by respiratory viruses, with positive 
results(38), these derive from a set of measures and 
should not be exclusively attributed to mask use.
Current guidelines(5) indicate that any patient 
should use simple masks in case of coughing to limit the 
potential dissemination of infected respiratory secretions. 
Special respirators (N95 or FFP2 masks), used to prevent 
small particle inhalation, are indicated for use by HSCT 
patients during the neutropenia phase, if they manage 
to tolerate this equipment, to avoid exposure to fungi 
during transportation near construction or renovation 
areas. There are no recommendations as to their use 
when leaving the unit if there are no construction areas 
nearby(5,33,39).
Considering the possible consequences of infectious 
processes for HSCT receivers, nurses and the health 
team working in this area need to be prepared for 
attendance to patients’ needs, and their practice needs 
to be based on scientific knowledge to support the 
implementation of confirmed effective measures. In this 
process, changes in HSCT need to be taken into account, 
such as the appearance of new antimicrobial agents, the 
use of less intense conditioning regimens, the increased 
age of HSCT receivers and the more frequent use of 
alternative stem cell donors; characteristics that can 
influence infection types and incidence rates.
Conclusion and final considerations
With a view to infection prevention in patients 
submitted to HSCT, this study provided support for 
decision making on the use of HEPA filters, protective 
isolation and masks by patients, health professionals 
and visitors, permitted improved nursing care delivery 
to these clients.
According to one evidence level I study, one 
moderate evidence level study and seven classified as 
weak evidence, HEPA filters should be used for allogeneic 
HSCT, especially in case of fungal infection episodes and 
during construction works or activities that produce dust 
at or near the hospitalization unit. As for autologous 
HSCT, the analyzed studies do not sustain the use of 
filters. Thus, further research is recommended to verify 
the need to use a HEPA filter for these patients.
About the use of protective isolation, although 
the only evidence level I publication indicated better 
transplantation results when it is used, in that study, 
the HEPA filter was part of protective isolation. Based on 
the results and conclusion of six weak-evidence studies, 
there is no indication to use protective isolation, as it 
would not be useful to prevent the main infections that 
affect patients in this phase.
Regarding masks, no studies with strong evidence 
were found to justify their use for infection prevention 
among HSCT receivers. Health professionals should use 
them as individual protective equipment, in accordance 
with CDC guidelines. CDC recommendations should also 
be followed related to allogeneic HSCT receivers’ use of 
special respirators.
These study results contribute to nursing care 
planning for HSCT patients. It is obvious that randomized 
controlled studies are needed to clarify existing questions 
and to support decision making on the application of these 
measures in clinical practice, which will help to improve 
the quality of care delivery to transplanted patients. 
In this process, not only nurses, but the entire team 
and health institutions’ efforts are important to achieve 
better results, greater client and family satisfaction, and 
also to reduce costs for the institution and patients.
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